Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT01991301
What this trial is testing

Carfilzomib for the Prevention of Graft Versus Host Disease

Who this might be right for
Graft-versus-host Disease
Sheba Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00539695
What this trial is testing

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Who this might be right for
Acute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more
Baylor College of Medicine 25
Early research (Phase 1)Not Yet RecruitingNCT07350057
What this trial is testing

A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children

Who this might be right for
GVHD (Acute or Chronic)
Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT01525407
What this trial is testing

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Malignant Neoplasm
Fred Hutchinson Cancer Center 83
Not applicableUnknownNCT02643589
What this trial is testing

Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 200
Not applicableStudy completedNCT02175615
What this trial is testing

Pharmacological Predictors of Successful Cyclosporine Acute GVHD Prophylaxis in Children Undergoing HSCT

Who this might be right for
Acute-graft-versus-host Disease
Lee Dupuis 105
Testing effectiveness (Phase 2)UnknownNCT05599256
What this trial is testing

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Not applicableUnknownNCT05078073
What this trial is testing

HBOT in the Treatment and Prevention of aGVHD

Who this might be right for
Hyperbaric Oxygen TherapyAcute-graft-versus-host Disease
Shandong Provincial Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Very early researchLooking for participantsNCT06731504
What this trial is testing

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Who this might be right for
Hematologic Malignancy
Duke University 10
Large-scale testing (Phase 3)Ended earlyNCT00117702
What this trial is testing

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Who this might be right for
Graft vs Host Disease
Technische Universität Dresden 24
Post-approval studies (Phase 4)Study completedNCT01009619
What this trial is testing

Azithromycin in Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeGraft RejectionLymphocytic Bronchiolitis+1 more
KU Leuven 83
Testing effectiveness (Phase 2)Study completedNCT00506922
What this trial is testing

Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)UnknownNCT06334367
What this trial is testing

Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT

Who this might be right for
GVHD
Wang Xin 40
Testing effectiveness (Phase 2)Study completedNCT02806375
What this trial is testing

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyeloproliferative Disorders
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00146614
What this trial is testing

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancies
Dana-Farber Cancer Institute 105
Large-scale testing (Phase 3)Study completedNCT05149365
What this trial is testing

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Who this might be right for
Acute-graft-versus-host DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 190
Not applicableNot Yet RecruitingNCT07010068
What this trial is testing

Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study

Who this might be right for
Malnutrition (Calorie)Stem Cell Transplant Complications
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 214
Next Page